Apoptosis in lymphocytic leukemias and lymphomas

Cancer Investigation

Volumn 20, Issue 5-6, 2002, Pages 737-748

  Schattner, Elaine J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OKT 3; PROTEIN BCL 2; PROTEIN MCL 1;

APOPTOSIS; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; BURKITT LYMPHOMA; CYTOTOXIC T LYMPHOCYTE; FOLLICULAR LYMPHOMA; GENE OVEREXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; LYMPHATIC LEUKEMIA; LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; REVIEW; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; INFECTION; LYMPHOCYTOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTO ONCOGENE;

APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; INFECTION; LEUKEMIA, LYMPHOCYTIC; LYMPHOMA, SMALL-CELL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036050489     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120002951     Document Type: Review

References (117)

1. Harris, N.L.; Jaffe, E.S.; Stein, H.; Banks, P.M.; Chan, J.K.; Cleary, M.L.; Delsol, G.; De Wolf-Peeters, C.; Falini, B.; Gatter, K.C. A Revised European-American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group. Blood 1994, 84, 1361-1392.
2. Harris, N.L.; Jaffe, E.S.; Diebold, J.; Flandrin, G.; Muller-Hermelink, H.K.; Vardiman, J.; Lister, T.A.; Bloomfield, C.D. World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997. J. Clin. Oncol. 1999, 17, 3835-3849.
3. Graninger, W.B.; Seto, M.; Boutain, B.; Goldman, P.; Korsmeyer, S.J. Expression of Bcl-2 and Bcl-2-Ig Fusion Transcripts in Normal and Neoplastic Cells. J. Clin. Invest. 1987, 80, 1512-1515.
4. Korsmeyer, S.J. Chromosomal Translocations in Lymphoid Malignancies Reveal Novel Proto-oncogenes. Annu. Rev. Immunol. 1992, 10, 785-807.
5. Dalla-Favera, R.; Gaidano, G. Molecular Biology of Lymphomas. In Principles and Practice of Oncology; DeVita, V.T., Hellman, S., Rosenberg, S.A., Eds.; Lippincott Williams and Wilkins: Philadelphia, PA, 2001.
6. Gottardi, D.; Alfarano, A.; De Leo, A.M.; Stacchini, A.; Aragno, M.; Rigo, A.; Veneri, D.; Zanotti, R.; Pizzolo, G.; Caligaris-Cappio, F. In Leukaemic CD5+ B Cells the Expression of BCL-2 Gene Family Is Shifted Toward Protection from Apoptosis. Br. J. Haematol. 1996, 94, 612-618.
7. Kitada, S.; Andersen, J.; Akar, S.; Zapata, J.M.; Takayama, S.; Krajewski, S.; Wang, H.G.; Zhang, X.; Bullrich, F.; Croce, C.M.; Rai, K.; Hines, J.; Reed, J.C. Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations with In Vitro and In Vivo Chemoresponses. Blood 1998, 91, 3379-3389.
8. Bernal, A.; Pastore, R.P.; Asgary, Z.; Keller, S.A.; Cesarman, E.; Liou, H.-C.; Schattner, E.J. Survival of Leukemic B Cells Promoted by Engagement of the Antigen Receptor. Blood 2001, 98, 3050-3057.
9. Tsukahara, T.; Kannagi, M.; Ohashi, T.; Kato, H.; Arai, M.; Nunez, G.; Iwanaga, Y.; Yamamoto, N.; Ohtani, K.; Nakamura, M.; Fujii, M. Induction of Bcl-x(L) Expression by Human T-Cell Leukemia Virus Type 1 Tax Through NF-kappaB in Apoptosis-Resistant T-Cell Transfectants with Tax. J. Virol. 1999, 73, 7981-7987.
10. Kawakami, A.; Nakashima, T.; Sakai, H.; Urayama, S.; Yamasaki, S.; Hida, A.; Tsuboi, M.; Nakamura, H.; Ida, H.; Migita, K.; Kawabe, Y.; Eguchi, K. Inhibition of Caspase Cascade by HTLV-I Tax Through Induction of NF-kappaB Nuclear Translocation. Blood 1999, 94, 3847-3854.
11. Bakhshi, A.; Jensen, J.P.; Goldman, P.; Wright, J.J.; McBride, O.W.; Epstein, A.L.; Korsmeyer, S.J. Cloning the Chromosomal Breakpoint of t(14; 18) Human Lymphomas: Clustering Around JH on Chromosome 14 and Near a Transcriptional Unit on 18. Cell 1985, 41, 899-906.
12. Tsujimoto, Y.; Cossman, J.; Jaffe, E.; Croce, C.M. Involvement of the Bcl-2 Gene in Human Follicular Lymphoma. Science 1985, 228, 1440-1443.
13. Weiss, L.M.; Warnke, R.A.; Sklar, J.; Cleary, M.L. Molecular Analysis of the t(14; 18) Chromosomal Translocation in Malignant Lymphomas. N. Engl. J. Med. 1987, 317, 1185-1189.
14. Krajewski, S.; Bodrug, S.; Gascoyne, R.; Berean, K.; Krajewska, M.; Reed, J.C. Immunohistochemical Analysis of Mcl-1 and Bcl-2 Proteins in Normal and Neoplastic Lymph Nodes. Am. J. Pathol. 1994, 145, 515-525.
15. Martinez-Valdez, H.; Guret, C.; de Bouteiller, O.; Fugier, I.; Banchereau, J.; Liu, Y.J. Human Germinal Center B Cells Express the Apoptosis-Inducing Genes Fas, c-myc, p53, and bax But Not the Survival Gene bcl-2. J. Exp. Med. 1996, 183, 971-977.
16. Rathmell, J.C.; Thompson, C.B. The Central Effectors of Cell Death in the Immune System. Annu. Rev. Immunol. 1999, 17, 781-828.
17. Yang, J.; Liu, X.; Bhalla, K.; Kim, C.N.; Ibrado, A.M.; Cai, J.; Peng, T.I.; Jones, D.P.; Wang, X. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked. Science 1997, 275, 1129-1132.
18. Shimizu, S.; Narita, M.; Tsujimoto, Y. Bcl-2 Family Proteins Regulate the Release of Apoptogenic Cytochrome c by the Mitochondrial Channel VDAC. Nature 1999, 399, 483-487.
19. Bouchon, A.; Krammer, P.H.; Walczak, H. Critical Role for Mitochondria in B Cell Receptor-Mediated Apoptosis. Eur. J. Immunol. 2000, 30, 69-77.
20. Muchmore, S.W.; Sattler, M.; Liang, H.; Meadows, R.P.; Harlan, J.E.; Yoon, H.S.; Nettesheim, D.; Chang, B.S.; Thompson, C.B.; Wong, S.L.; Ng, S.L.; Fesik, S.W. X-Ray and NMR Structure of Human Bcl-xL, an Inhibitor of Programmed Cell Death. Nature 1996, 381, 335-341.
21. Reed, J.C.; Jurgensmeier, J.M.; Matsuyama, S. Bcl-2 Family Proteins and Mitochondria. Biochim. Biophys. Acta 1998, 1366, 127-137.
22. Shi, Y. A Structural View of Mitochondria-Mediated Apoptosis. Nat. Struct. Biol. 2001, 8, 394-401.
23. Wang, H.G.; Pathan, N.; Ethell, I.M.; Krajewski, S.; Yamaguchi, Y.; Shibasaki, F.; McKeon, F.; Bobo, T.; Franke, T.F.; Reed, J.C. Ca2+-Induced Apoptosis Through Calcineurin Dephosphorylation of BAD. Science 1999, 284, 339-343.
24. Zha, J.; Weiler, S.; Oh, K.J.; Wei, M.C.; Korsmeyer, S.J. Posttranslational N-Myristoylation of BID as a Molecular Switch for Targeting Mitochondria and Apoptosis. Science 2000, 290, 1761-1765.
25. Luo, X.; Budihardjo, I.; Zou, H.; Slaughter, C., Wang, X. Bid, a Bcl2 Interacting Protein, Mediates Cytochrome C Release from Mitochondria in Response to Activation of Cell Surface Death Receptors. Cell 1998, 94, 481-490.
26. Rozman, C.; Montserrat, E. Chronic Lymphocytic Leukemia. N. Engl. J. Med. 1995, 333, 1052-1057.
27. Caligaris-Cappio, F.; Hamblin, T.J. B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather. J. Clin. Oncol. 1999, 17, 399-408.
28. Schroeder, H.W., Jr.; Dighiero, G. The Pathogenesis of Chronic Lymphocytic Leukemia: Analysis of the Antibody Repertoire. Immunol. Today 1994, 15, 288-294.
29. Caligaris-Cappio, F. B-Chronic Lymphocytic Leukemia: A Malignancy of Anti-self B Cells. Blood 1996, 87, 2615-2620.
30. Dameshek, W. Chronic Lymphocytic Leukemia - An Accumulative Disease of Immunolgically Incompetent Lymphocytes. Blood 1967, 29, 566-584.
31. Schattner, E.J. CD40 Ligand in CLL Pathogenesis and Therapy. Leuk. Lymphoma 2000, 37, 461-472.
32. Lagneaux, L.; Delforge, A.; Bron, D.; De Bruyn, C.; Stryckmans, P. Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells are Rescued from Apoptosis by Contact with Normal Bone Marrow Stromal Cells. Blood 1998, 91, 2387-2396.
33. Gamberale, R.; Geffner, J.R.; Trevani, A.; Chernavsky, A.; Scolnik, M.; Arrosagaray, G.; Sarmiento, M.; Giordano, M. Immune Complexes Inhibit Apoptosis of Chronic Lymphocytic Leukaemia B Cells. Br. J. Haematol. 1999, 107, 870-876.
34. Cordingley, F.T.; Bianchi, A.; Hoffbrand, A.V.; Reittie, J.E.; Heslop, H.E.; Vyakarnam, A.; Turner, M.; Meager, A.; Brenner, M.K. Tumour Necrosis Factor as an Autocrine Tumour Growth Factor for Chronic B-Cell Malignancies. Lancet 1988, 1, 969-971.
35. Dancescu, M.; Rubio-Trujillo, M.; Biron, G.; Bron, D.; Delespesse, G.; Sarfati, M. Interleukin 4 Protects Chronic Lymphocytic Leukemic B Cells from Death by Apoptosis and Upregulates Bcl-2 Expression. J. Exp. Med. 1992, 176, 1319-1326.
36. Romano, M.F.; Lamberti, A.; Tassone, P.; Alfinito, F.; Costantini, S.; Chiurazzi, F.; Defrance, T.; Bonelli, P.; Tuccillo, F.; Turco, M.C.; Venuta, S. Triggering of CD40 Antigen Inhibits Fludarabine-Induced Apoptosis in B Chronic Lymphocytic Leukemia Cells. Blood 1998, 92, 990-995.
37. Furman, R.R.; Asgary, Z.; Mascarenhas, J.O.; Liou, H.-C.; Schattner, E.J. Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells. J. Immunol. 2000, 164, 2200-2206.
38. Kitada, S.; Zapata, J.M.; Andreeff, M.; Reed, J.C. Bryostatin and CD40-Ligand Enhance Apoptosis Resistance and Induce Expression of Cell Survival Genes in B-Cell Chronic Lymphocytic Leukaemia. Br. J. Haematol. 1999, 106, 995-1004.
39. Wang, D.; Freeman, G.J.; Levine, H.; Ritz, J.; Robertson, M.J. Role of the CD40 and CD95 (APO-1/Fas) Antigens in the Apoptosis of Human B-Cell Malignancies. Br. J. Haematol. 1997, 97, 409-417.
40. Younes, A.; Snell, V.; Consoli, U.; Clodi, K.; Zhao, S.; Palmer, J.L.; Thomas, E.K.; Armitage, R.J.; Andreeff, M. Elevated Levels of Biologically Active Soluble CD40 Ligand in the Serum of Patients with Chronic Lymphocytic Leukaemia. Br. J. Haematol. 1998, 100, 135-141.
41. Granziero, L.; Ghia, P.; Circosta, P.; Gottardi, D.; Strola, G.; Geuna, M.; Montagna, L.; Piccoli, P.; Chilosi, M.; Caligaris-Cappio, F. Survivin is Expressed on CD40 Stimulation and Interfaces Proliferation and Apoptosis in B-Cell Chronic Lymphocytic Leukemia. Blood 2001, 97, 2777-2783.
42. Roy, M.; Waldschmidt, T.; Aruffo, A.; Ledbetter, J.A.; Noelle, R.J. The Regulation of the Expression of Gp39, the CD40 Ligand, on Normal and Cloned CD4+ T Cells. J. Immunol. 1993, 151, 2497-2510.
43. Tallman, M.S.; Hakimian, D. Purine Nucleoside Analogs: Emerging Roles in Indolent Lymphoproliferative Disorders. Blood 1995, 86, 2463-2474.
44. Rai, K.R.; Peterson, B.L.; Appelbaum, F.R.; Kolitz, J.; Elias, L.; Shepherd, L.; Hines, J.; Threatte, G.A.; Larson, R.A.; Cheson, B.D.; Schiffer, C.A. Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia. N. Engl. J. Med. 2000, 343, 1750-1757.
45. Trentin, L.; Zambello, R.; Sancetta, R.; Facco, M.; Cerutti, A.; Perin, A.; Siviero, M.; Basso, U.; Bortolin, M.; Adami, F.; Agostini, C.; Semenzato, G. B Lymphocytes from Patients with Chronic Lymphoproliferative Disorders Are Equipped with Different Costimulatory Molecules. Cancer Res. 1997, 57, 4940-4947.
46. Schattner, E.J.; Mascarenhas, J.; Reyfman, I.; Koshy, M.; Woo, C.; Friedman, S.M.; Crow, M.K. Chronic Lymphocytic Leukemia B Cells Can Express CD40 Ligand and Demonstrate T-Cell Type Costimulatory Capacity. Blood 1998, 91, 2689-2697.
47. Clodi, K.; Asgary, Z.; Zhao, S.; Kliche, K.-O.; Cabanillas, F.; Andreeff, M.; Younes, A. Coexpression of CD40 and CD40 Ligand in B-Cell Lymphoma Cells. Br. J. Haematol. 1998, 103, 270-275.
48. Chen, Z.; Hagler, J.; Palombella, V.J.; Melandri, F.; Scherer, D.; Ballard, D.; Maniatis, T. Signal-Induced Site-Specific Phosphorylation Targets I Kappa B Alpha to the Ubiquitin-Proteasome Pathway. Genes Dev. 1995, 9, 1586-1597.
49. Barnes, P.J.; Karin, M. Nuclear Factor-kappaB: A Pivotal Transcription Factor in Chronic Inflammatory Diseases. N. Engl. J. Med. 1997, 336, 1066-1071.
50. Baeuerle, P.A.; Baltimore, D. NF-kappaB: Ten Years After. Cell 1996, 87, 13-20.
51. Ghosh, S.; May, M.J.; Kopp, E.B. NF-kappaB and Rel Proteins: Evolutionarily Conserved Mediators of Immune Responses. Annu. Rev. Immunol. 1998, 16, 225-260.
52. Baldwin, A.S. Control of Oncogenesis and Cancer Therapy Resistance by the Transcription Factor NF-kappaB. J. Clin. Invest. 2001, 107, 241-246.
53. Beg, A.A.; Baltimore, D. An Essential Role for NF-kappaB in Preventing TNF-Alpha-Induced Cell Death. Science 1996, 274, 782-784.
54. Van Antwerp, D.J.; Martin, S.J.; Kafri, T.; Green, D.R.; Verma, I.M. Suppression of TNF-Alpha-Induced Apoptosis by NF-kappaB. Science 1996, 274, 787-789.
55. Wang, C.Y.; Mayo, M.W.; Baldwin, A.S., Jr. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-kappaB. Science 1996, 274, 784-787.
56. Wang, C.Y.; Mayo, M.W.; Korneluk, R.G.; Goeddel, D.V.; Baldwin, A.S., Jr. NF-kappaB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation. Science 1998, 281, 1680-1683.
57. Wang, C.Y.; Guttridge, D.C.; Mayo, M.W.; Baldwin, A.S., Jr. NF-kappaB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 to Preferentially Suppress Chemotherapy-Induced Apoptosis. Mol. Cell. Biol. 1999, 19, 5923-5929.
58. Lee, H.H.; Dadgostar, H.; Cheng, Q.; Shu, J.; Cheng, G. NF-kappaB-Mediated Up-Regulation of Bcl-x and Bfl-1/A1 Is Required for CD40 Survival Signaling in B Lymphocytes. Proc. Natl Acad. Sci. USA 1999, 96, 9136-9141.
59. Grumont, R.J.; Rourke, I.J.; Gerondakis, S. Rel-Dependent Induction of A1 Transcription Is Required to Protect B Cells from Antigen Receptor Ligation-Induced Apoptosis. Genes Dev. 1999, 13, 400-411.
60. Broder, S.; Bunn, P.A.; Jaffe, E.S.; Blattner, W.; Gallo, R.C.; Wong-Staal, F.; Waldmann, T.A.; De Vita, V.T. NIH Conference, T-Cell Lymphoproliferative Syndrome Associated with Human T-Cell Leukemia/Lymphoma Virus. Ann. Int. Med. 1984, 100, 543-557.
61. Kondo, T.; Nonaka, H.; Miyamoto, N.; Yoshida, R.; Matsue, Y.; Ohguchi, Y.; Inouye, H.; Komoda, H.; Hinuma, Y.; Hanaoka, M. Incidence of Adult T-Cell Leukemia-Lymphoma and Its Familial Clustering. Int. J. Cancer 1985, 35, 749-751.
62. Rosenblatt, J.D.; Chen, I.S.; Wachsman, W. Infection with HTLV-I and HTLV-II: Evolving Concepts. Semin. Hematol. 1988, 25, 230-246.
63. Sarma, P.S.; Gruber, J. Human T-Cell Lymphotropic Viruses in Human Diseases. J. Natl Cancer Inst. 1990, 82, 1100-1106.
64. Kuefler, P.R.; Bunn, P.A. Adult T-Cell Leukaemia/-Lymphoma. Clin. Haematol. 1986, 15, 695-726.
65. Hollsberg, P.; Hafler, D.A. Seminars in Medicine of the Beth Israel Hospital. Boston. Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection. N. Engl. J. Med. 1993, 328, 1173-1182.
66. Zhao, L.J.; Giam, C.Z. Interaction of the Human T-Cell Lymphotrophic Virus Type I (HTLV-I) Transcriptional Activator Tax with Cellular Factors that Bind Specifically to the 21-Base-Pair Repeats in the HTLV-I Enhancer. Proc. Natl Acad. Sci. USA 1991, 88, 11445-11449.
67. Duyao, M.P.; Kessler, D.J.; Spicer, D.B.; Sonenshein, G.E. Transactivation of the Murine c-myc Gene by HTLV-1 Tax Is Mediated by NFκB. AIDS Res. Hum. Retrovir. 1992, 8, 752-754.
68. Uittenbogaard, M.N.; Armstrong, A.P.; Chiaramello, A.; Nyborg, J.K. Human T-Cell Leukemia Virus Type I Tax Protein Represses Gene Expression Through the Basic Helix-Loop-Helix Family of Transcription Factors. J. Biol. Chem. 1994, 269, 22466-22469.
69. Perini, G.; Wagner, S.; Green, M.R. Recognition of bZIP Proteins by the Human T-Cell Leukaemia Virus Transactivator Tax. Nature 1995, 376, 602-605.
70. Kwok, R.P.; Laurance, M.E.; Lundblad, J.R; Goldman, P.S.; Shih, H.; Connor, L.M.; Marriott, S.J.; Goodman, R.H. Control of cAMP-Regulated Enhancers by the Viral Transactivator Tax Through CREB and the Co-activator CBP. Nature 1996, 380, 642-646.
71. Kanno, T.; Franzoso, G.; Siebenlist, U. Human T-Cell Leukemia Virus Type I Tax-Protein-Mediated Activation of NF-kappa B from p100 (NF-kappa B2)-Inhibited Cytoplasmic Reservoirs. Proc. Natl Acad. Sci. USA 1994, 91, 12634-12638.
72. Hirai, H.; Suzuki, T.; Fujisawa, J.; Inoue, J.; Yoshida, M. Tax Protein of Human T-Cell Leukemia Virus Type I Binds to the Ankyrin Motifs of Inhibitory Factor kappa B and Induces Nuclear Translocation of Transcription Factor NF-kappa B Proteins for Transcriptional Activation. Proc. Natl Acad. Sci. USA 1994, 91, 3584-3588.
73. Beraud, C.; Sun, S.C.; Ganchi, P.; Ballard, D.W.; Greene, W.C. Human T-Cell Leukemia Virus Type I Tax Associates with and Is Negatively Regulated by the NF-kappa B2 p100 Gene Product: Implications for Viral Latency. Mol. Cell. Biol. 1994, 14, 1374-1382.
74. Yin, M.J.; Christerson, L.B.; Yamamoto, Y.; Kwak, Y.T.; Xu, S.; Mercurio, F.; Barbosa, M.; Cobb, M.H.; Gaynor, R.B. HTLV-I Tax Protein Binds to MEKK1 to Stimulate IkappaB Kinase Activity and NF-kappaB Activation. Cell 1998, 93, 875-884.
75. Geleziunas, R.; Ferrell, S.; Lin, X.; Mu, Y.; Cunningham, E.T.; Grant, M.; Connelly, M.A.; Hambor, J.E.; Marcu, K.B.; Greene, W.C. Human T-Cell Leukemia Virus Type 1 Tax Induction of NF-kappaB Involves Activation of the IkappaB Kinase Alpha (IKKalpha) and IKKbeta Cellular Kinases. Mol. Cell Biol. 1998, 18, 5157-5165.
76. Li, X.H.; Murphy, K.M.; Palka, K.T.; Surabhi, R.M.; Gaynor, R.B. The Human T-Cell Leukemia Virus Type-1 Tax Protein Regulates the Activity of the IkappaB Kinase Complex. J. Biol. Chem. 1999, 274, 34417-34424.
77. Hecht, J.L.; Aster, J.C. Molecular Biology of Burkitt's Lymphoma. J. Clin. Oncol. 2000, 18, 3707-3721.
78. Pulvertaft, J.V. A Study of Malignant Tumours in Nigeria by Short-Term Tissue Culture. J. Clin. Pathol. 1965, 18, 261-271.
79. Magrath, I.T.; Pizzo, P.A.; Whang-Peng, J.; Douglass, E.C.; Alabaster, O.; Gerber, P.; Freeman, C.B.; Novikovs, L. Characterization of Lymphoma-Derived Cell Lines: Comparison of Cell Lines Positive and Negative for Epstein-Barr Virus Nuclear Antigen. I. Physical, Cytogenetic, and Growth Characteristics. J. Natl Cancer Inst. 1980, 64, 465-476.
80. Grogan, T.M.; Warnke, R.A.; Kaplan, H.S. A Comparative Study of Burkitt's and Non-Burkitt's Undifferentiated Malignant Lymphoma: Immunologic, Cytochemical, Ultrastructural, Cytologic, Histopathologic, Clinical and Cell Culture Features. Cancer 1982, 49, 1817-1828.
81. MacDonald, I.; Wang, H.; Grand, R.; Armitage, R.J.; Fanslow, W.C.; Gregory, C.D.; Gordon, J. Transforming Growth Factor-Beta 1 Cooperates with Anti-immunoglobulin for the Induction of Apoptosis in Group I (Biopsy-Like) Burkitt Lymphoma Cell Lines. Blood 1996, 87, 1147-1154.
82. Gregory, C.D.; Dive, C.; Henderson, S.; Smith, C.A.; Williams, G.T.; Gordon, J.; Rickinson, A.B. Activation of Epstein-Barr Virus Latent Genes Protects Human B Cells from Death by Apoptosis. Nature 1991, 349, 612-614.
83. Kaptein, J.S.; Lin, C.K.E.; Wang, C.L.; Nguyen, T.T.; Kalunta, C.I.; Park, E.; Chen, F.S.; Lad, P.M. Anti-IgM-Mediated Regulation of c-myc and Its Possible Relationship to Apoptosis. J. Biol. Chem. 1996, 271, 18875-18884.
84. Schattner, E.J.; Elkon, K.B.; Yoo, D.H.; Tumang, J.; Krammer, P.H.; Crow, M.K.; Friedman, S.M. CD40 Ligation Induces Apo-1/Fas Expression on Human B Lymphocytes and Facilitates Apoptosis Through the Apo-1/Fas Pathway. J. Exp. Med. 1995, 182, 1557-1565.
85. Schattner, E.J.; Mascarenhas, J.; Bishop, J.; Yoo, D.H.; Chadbum, A.; Crow, M.K.; Friedman, S.M. CD4+ T-Cell Induction of Fas-Mediated Apoptosis in Burkitt's Lymphoma B Cells. Blood 1996, 88, 1375-1382.
86. Lens, S.M.; Tesselaar, K.; den Drijver, B.F.; van Oers, M.H.; van Lier, R.A. A Dual Role for Both CD40-Ligand and TNF-Alpha in Controlling Human B Cell Death. J. Immunol. 1996, 156, 507-514.
87. An, S.; Knox, K.A. Ligation of CD40 Rescues Ramos-Burkitt Lymphoma B Cells from Calcium Ionophore- and Antigen Receptor-Triggered Apoptosis by Inhibiting Activation of the Cysteine Protease CPP32/Yama and Cleavage of Its Substrate PARP. FEBS Lett. 1996, 386, 115-122.
88. Alam, M.K.; Davison, S.; Siddiqui, N.; Norton, J.D.; Murphy, J.J. Ectopic Expression of Bcl-2, But Not Bcl-xL Rescues Ramos B Cells from Fas-Mediated Apoptosis. Eur. J. Immunol. 1997, 27, 3485-3491.
89. Swinnen, L.J.; Costanzo-Nordin, M.R.; Fisher, S.G.; O'Sullivan, E.J.; Johnson, M.R.; Heroux, A.L.; Dizikes, G.J.; Pifarre, R.; Fisher, R.I. Increased Incidence of Lymphoproliferative Disorder After Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients. N. Engl. J. Med. 1990, 323, 1723-1728.
90. Opelz, G.; Henderson, R. Incidence of Non-Hodgkin Lymphoma in Kidney and Heart Transplant Recipients. Lancet 1993, 342, 1514-1516.
91. Chadburn, A.; Chen, J.M.; Hsu, D.T.; Frizzera, G.; Cesarman, E.; Garrett, T.J.; Mears, J.G.; Zangwill, S.D.; Addonizio, L.J.; Michler, R.E.; Knowles, D.M. The Morphologic and Molecular Genetic Categories of Posttransplantation Lymphoproliferative Disorders Are Clinically Relevant. Cancer 1998, 82, 1978-1987.
92. Papadopoulos, E.B.; Ladanyi, M.; Emanuel, D.; Mackinnon, S.; Boulad, F.; Carabasi, M.H.; Castro-Malaspina, H.; Childs, B.H.; Gillio, A.P.; Small, T.N.; et al., Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders After Allogeneic Bone Marrow Transplantation. N. Engl. J. Med. 1994, 330, 1185-1191.
93. Rooney, C.M.; Smith, C.A.; Ng, C.Y.; Loftin, S.; Li, C.; Krance, R.A.; Brenner, M.K.; Heslop, H.E. Use of Gene-Modified Virus-Specific T Lymphocytes to Control Epstein-Barr-Virus-Related Lymphoproliferation. Lancet 1995, 345, 9-13.
94. Cesarman, E.; Chadbum, A.; Liu, Y.F.; Migliazza, A.; Dalla-Favera, R.; Knowles, D.M. BCL-6 Gene Mutations in Posttransplantation Lymphoproliferative Disorders Predict Response to Therapy and Clinical Outcome. Blood 1998, 92, 2294-2302.
95. Cesarman, E.; Chang, Y.; Moore, P.S.; Said, J.W.; Knowles, D.M. Kaposi's Sarcoma-Associated Herpes-virus-Like DNA Sequences in AIDS-Related Body-Cavity-Based Lymphomas. N. Engl. J. Med. 1995, 332, 1186-1191.
96. Keller, S.A.; Schattner, E.J.; Cesarman, E. Inhibition of NF-kappaB Induces Apoptosis of KSHV-Infected Primary Effusion Lymphoma Cells. Blood 2000, 96, 2537-2542.
97. Silvestri, F.; Baccarani, M. Hepatitis C Virus-Related Lymphomas. Br. J. Haematol. 1997, 99, 475-480.
98. Dammacco, F.; Gatti, P.; Sansonno, D. Hepatitis C Virus Infection, Mixed Cryoglobulinemia, and Non-Hodgkin's Lymphoma: An Emerging Picture. Leuk. Lymphoma 1998, 31, 463-476.
99. Zelenetz, A.D.; Chen, T.T.; Levy, R. Clonal Expansion in Follicular Lymphoma Occurs Subsequent to Antigenic Selection. J. Exp. Med. 1992, 176, 1137-1148.
100. Bahler, D.W.; Levy, R. Clonal Evolution of a Follicular Lymphoma: Evidence for Antigen Selection. Proc. Natl Acad. Sci. USA 1992, 89, 6770-6774.
101. Jain, R.; Roncella, S.; Hashimoto, S.; Carbone, A.; Francia di Celle, P. ; Foa, R.; Ferrarini, M.; Chiorazzi, N. A Potential Role for Antigen Selection in the Clonal Evolution of Burkitt's Lymphoma. J. Immunol. 1994, 153, 45-52.
102. Tamaru, J.; Hummel, M.; Marafioti, T.; Kalvelage, B.; Leoncini, L.; Minacci, C.; Tosi, P.; Wright, D.; Stein, H. Burkitt's Lymphomas Express VH Genes with a Moderate Number of Antigen-Selected Somatic Mutations. Am. J. Pathol. 1995, 147, 1398-1407.
103. Ottensmeier, C.H.; Thompsett, A.R.; Zhu, D.; Wilkins, B.S.; Sweetenham, J.W.; Stevenson, F.K. Analysis of VH Genes in Follicular and Diffuse Lymphoma Shows Ongoing Somatic Mutation and Multiple Isotype Transcripts in Early Disease with Changes During Disease Progression. Blood 1998, 91, 4292-4299.
104. Borche, L.; Lim, A.; Binet, J.L.; Dighiero, G. Evidence that Chronic Lymphocytic Leukemia B Lymphocytes Are Frequently Committed to Production of Natural Autoantibodies. Blood 1990, 76, 562-569.
105. Kipps, T.J.; Carson, D.A. Autoantibodies in Chronic Lymphocytic Leukemia and Related Systemic Autoimmune Diseases. Blood 1993, 81, 2475-2487.
106. Riboldi, P.; Gaidano, G.; Schettino, E.W.; Steger, T.G.; Knowles, D.M.; Dalla-Favera, R.; Casali, P. Two Acquired Immunodeficiency Syndrome-Associated Burkitt's Lymphomas Produce Specific Anti-i IgM Cold Agglutinins Using Somatically Mutated VH4-21 Segments. Blood 1994, 83, 2952-2961.
107. Roncella, S.; Cutrona, G.; Favre, A.; Ulivi, M.; Fais, F.; Signorini, A. ; Grossi, C.E.; Chiorazzi, N.; Ferrarini, M. Apoptosis of Burkitt's Lymphoma Cells Induced by Specific Interaction of Surface IgM with a Self-Antigen: Implications for Lymphomagenesis in Acquired Immunodeficiency Syndrome. Blood 1996, 88, 599-608.
108. Lo Coco, F.; Gaidano, G.; Louie, D.C.; Offit, K.; Chaganti, R.S.; Dalla-Favera, R. p53 Mutations Are Associated with Histologic Transformation of Follicular Lymphoma. Blood 1993, 82, 2289-2295.
109. Sander, C.A.; Yano, T.; Clark, H.M.; Harris, C.; Longo, D.L.; Jaffe, E.S.; Raffeld, M. p53 Mutation Is Associated with Progression in Follicular Lymphomas. Blood 1993, 82, 1994-2004.
110. Elenitoba-Johnson, K.S.J.; Gascoyne, R.D.; Lim, M.S.; Chhanabai, M.; Jaffe, E.S.; Raffeld, M. Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 Are Associated with Histologic Progression in Follicle Center Lymphoma. Blood 1998, 91, 4677-4685.
111. Wotherspoon, A.C.; Doglioni, C.; Diss, T.C.; Pan, L.; Moschini, A.; de Boni, M.; Isaacson, P.G. Regression of Primary Low-Grade B-Cell Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue Type After Eradication of Helicobacter pylori. Lancet 1993, 342, 575-577.
112. Bayerdorffer, E.; Neubauer, A.; Rudolph, B.; Thiede, C.; Lehn, N.; Eidt, S.; Stolte, M. Regression of Primary Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue Type After Cure of Helicobacter pylori Infection. MALT Lymphoma Study Group. Lancet 1995, 345, 1591-1594.
113. Hussell, T.; Isaacson, P.G.; Crabtree, J.E.; Dogan, A.; Spencer, J. Immunoglobulin Specificity of Low Grade B Cell Gastrointestinal Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type. Am. J. Pathol. 1993, 142, 285-292.
114. Du, M.; Diss, T.C.; Xu, C.; Peng, H.; Isaacson, P.G.; Pan, L. Ongoing Mutation in MALT Lymphoma Immunoglobulin Gene Suggests That Antigen Stimulation Plays a Role in the Clonal Expansion. Leukemia 1996, 10, 1190-1197.
115. Hussell, T.; Isaacson, P.G.; Crabtree, J.E.; Spencer, J. Helicobacterpylori-Specific Tumour-Infiltrating T Cells Provide Contact Dependent Help for the Growth of Malignant B Cells in Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue. J. Pathol. 1996, 178, 122-127.
116. Wright, D.H. Burkitt's Lymphoma: A Review of the Pathology, Immunology, and Possible Etiologic Factors. Pathol. Annu. 1971, 6, 337-363.
117. Schattner, E.; Friedman, S.M. Fas Expression and Apoptosis in Human B Cells. Immunol. Res. 1996, 15, 246-257.